Tag: ATAC

SABCS 2020: Updated monarchE trial shows abemaciclib continues to benefit patients with high-risk, HR-positive, HER2-negative, early-stage breast cancer

Presented By

Dr Priya Rastogi, University of Pittsburgh, Pennsylvania

Trial

monarchE, PALLAS, Penelope-B

Journal

Physician's Weekly

Conference

SABCS 2020